AMPEL BioSolutions Company

AMPEL is a precision medicine company commercializing LDTs that predict disease status, molecular pathways, and best drug options.

Total Funding: 12510000.0
Headquarters: Charlottesville, Virginia, United States
Funding Status: Seed
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Last Funding Type: Debt Financing
Technology: Data-driven Technologies
Last Funding Date: 2022-12-13
Investors Number: 1.0
Founded Date: 2013-07-13
Industry: Clinical Development